Comparison between Evoq Remedies IPO and Shigan Quantum Technologies IPO.
Evoq Remedies IPO is a SME Fixed Price IPO proposed to list at BSE SME while Shigan Quantum Technologies IPO is a SME Fixed Price proposed to list at NSE SME.
| Evoq Remedies IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Finshore Management Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the Shigan Quantum Technologies IPO is up to ₹21.56 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of Shigan Quantum Technologies IPO is ₹50.00 per share.
| Evoq Remedies IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹27.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 3000 shares |
| Fresh Issue Size | 34,20,000 shares | 43,11,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.23 Cr | up to ₹21.56 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,20,000 shares | 43,11,000 shares |
| Issue Size Total (Amount) | up to ₹9.23 Cr | up to ₹21.56 Cr |
Evoq Remedies IPO opens on Mar 17, 2022, while Shigan Quantum Technologies IPO opens on Feb 28, 2022. The closing date of Evoq Remedies IPO and Shigan Quantum Technologies IPO is Mar 22, 2022, and Mar 03, 2022, respectively.
| Evoq Remedies IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 17, 2022 | Feb 28, 2022 |
| Issue Close | Mar 22, 2022 | Mar 03, 2022 |
| Basis Of Allotment (Tentative) | Mar 25, 2022 | Mar 08, 2022 |
| Initiation of Refunds (Tentative) | Mar 28, 2022 | Mar 09, 2022 |
| Credit of Share (Tentative) | Mar 29, 2022 | Mar 10, 2022 |
| Listing date (Tentative) | Mar 30, 2022 | Mar 11, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Evoq Remedies IPO P/E ratio is 33.75, as compared to Shigan Quantum Technologies IPO P/E ratio of 12.41.
| Evoq Remedies IPO | Shigan Quantum Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 73.53 | 73.63 | ||||
| P/E Ratio | 33.75 | 12.41 | ||||
| Market Cap | ₹36.72 Cr. | ₹86.08 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | 0.09 | |||||
| EPS | ₹10.05 | ₹2.77 | ||||
| RoNW | 96.94 | 20.84 |
In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Shigan Quantum Technologies IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and in Shigan Quantum Technologies IPO.
| Evoq Remedies IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,80,000 shares | 2,28,000 shares |
| QIB | ||
| NII | 17,10,000 shares | 21,54,000 shares |
| RII | 17,10,000 shares | 21,57,000 shares |
| Employee | ||
| Others | ||
| Total | 34,20,000 shares | 43,11,000 shares |
Evoq Remedies IPO subscribed 1.67x in total, whereas Shigan Quantum Technologies IPO subscribed 17.95x.
| Evoq Remedies IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.30x | 27.70x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.03x | 8.21x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.67x | 17.95x |
